The expression of genes that engender de novo hepatic lipogenesis, lipid storage, and NAFLD pathogenesis was associated SREBP1 and FABP4 mRNA expression [55,56]. Here, FABP4 is linked to metabolic dysfunction-associated steatotic liver disease.